References
- Almonte M, Ferreccio C, Luciani S, et al. (2015) Visual inspection after acetic acid (VIA) is highly heterogeneous in primary cervical screening in Amazonian Peru. PLoS one, 10, 115355-67
- Argyri E, Papaspyridakos S, Tsimplaki E, et al (2013). A cross sectional study of HPV type prevalence according to age and cytology. BMC Infect Dis, 13, 53-8. https://doi.org/10.1186/1471-2334-13-53
- Bhatla N, Dar L, Patro AR, et al (2009). Can human HPV in Healthy Women of North East India papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol, 33, 446-50. https://doi.org/10.1016/j.canep.2009.10.013
- Cox JT, Castle PE, Behrens CM, et al (2013). Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study. Am J Obstet Gynecol, 208, 184.
- de Bie RP, Schmeink CE, Bakkers JM, et al (2011) The indicating FTA elute cartridge a solid sample carrier to detect highrisk HPV and high-grade cervical lesions. J Mol Diagn, 13, 371-6. https://doi.org/10.1016/j.jmoldx.2011.02.003
- Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No.11[Internet]. Lyon, France: International Agency for Research on Cancer.
- Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al (2005). Cost effectiveness of cervical cancer screening in five developing countries. N Engl J Med, 353, 2158-68. https://doi.org/10.1056/NEJMsa044278
- Gustavsson I, Lindell M, Wilander E, et al (2009) Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol, 46, 112-116 https://doi.org/10.1016/j.jcv.2009.06.021
- Gyllensten U, Gustavsson I, Lindell M, et al (2012). Primary high-risk HPV screening for cervical cancer in postmenopausal women. Gynecol Oncol, 125, 343-5 https://doi.org/10.1016/j.ygyno.2012.01.036
- Huh WK, Ault KA, Chelmow D, et al (2015). Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance. Gynecol Oncol, 136, 178-82. https://doi.org/10.1016/j.ygyno.2014.12.022
- Jemal A, Bray F, Center MM, et al. Global cancer statistics (2011). CA Cancer J Clin, 61, 69-90 https://doi.org/10.3322/caac.20107
- Kailash U, Hedau S, Gopalkrishna V, et al. (2002). A simple 'paper smear' method for dry collection, transport and storage of cervical cytological specimens for rapid screening of HPV infection by PCR. J Med Microbiol, 51, 606-10. https://doi.org/10.1099/0022-1317-51-7-606
- Katyal S, Mehrotra R (2011). Complementary procedures in cervical cancer screening in low resource settings. J Obstet Gynaecol India, 61, 436-8 https://doi.org/10.1007/s13224-011-0067-y
- Khan MJ, Castle PE, Lorincz AT, et al. (2005). The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst, 97, 1072-9. https://doi.org/10.1093/jnci/dji187
- Kim K1, Kim JJ, Kim SM, et al (2012). Prevalence and determinants of high-risk human papillomavirus infection in women with high socioeconomic status in Seoul, Republic of Korea. Asian Pac J Cancer Prev, 13, 269-73. https://doi.org/10.7314/APJCP.2012.13.1.269
- Kitchener HC, Almonte M, Thomson C et al (2009). HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol, 10, 672-82. https://doi.org/10.1016/S1470-2045(09)70156-1
- Leinonen MK, Nieminen P, Lonnberg S, et al (2012). Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland. BMJ, 345, 77896-906.
- Malila N, Leinonen M, Kotaniemi-Talonen L, et al (2013). The HPV test has similar sensitivity but more over diagnosis than the Pap test--a randomised health services study on cervical cancer screening in Finland. Int J Cancer, 132, 2141-7 https://doi.org/10.1002/ijc.27850
- Monsonego J1, (2004). Colposcopy: the value of HPV testing in clinical practice. Gynecol Obstet Fertil, 32, 62-74. https://doi.org/10.1016/j.gyobfe.2003.10.025
- Monsonego J, Cox JT, Behrens C, et al (2015). Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial. Gynecol Oncol, 137, 47-54.
- Ogilvie GS, Krajden M, van Niekerk DJ, et al (2012). Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study. Br J Cancer, 107, 1917-24. https://doi.org/10.1038/bjc.2012.489
- Parashari A, Singh V. (2013) Reasons for variation in sensitivity and specificity of visual inspection with acetic acid (VIA) for the detection of pre- cancer and cancer lesions of uterine cervix. Asian Pac J Cancer Prev, 14, 7761-2. https://doi.org/10.7314/APJCP.2013.14.12.7761
- Parham GP, Mwanahamuntu MH, Pfaendler KS, et al (2010). eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis, 14, 167-73. https://doi.org/10.1097/LGT.0b013e3181cd6d5e
- Pimple S, Shastri SS. (2014). Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid. Indian J Cancer, 5, 117-23.
- Phongsavan K, Gustavsson I, Marions L, et al (2012). Detection of human papillomavirus among women in Laos: feasibility of using filter paper card and prevalence of high-risk types. Int J Gynecol Cancer, 22, 1398-406. https://doi.org/10.1097/IGC.0b013e3182664b6b
- Rai AK, Das D, Kataki AC, et al. (2014). Hybrid capture 2 assay based evaluation of high-risk HPV status in healthy women of north-east India. Asian Pac J Cancer Prev, 15, 861-5. https://doi.org/10.7314/APJCP.2014.15.2.861
- Ramshankar V, Soundara VT, Shyamsundar V, et al. (2014). Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Asian Pac J Cancer Prev, 15, 8351-9. https://doi.org/10.7314/APJCP.2014.15.19.8351
- Rijkaart DC, Heideman DA, Coupe VM, et al (2012). High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNApositive women with normal cytology. J Clin Microbiol. 50, 2390-6. https://doi.org/10.1128/JCM.06587-11
- Ronco G, Dillner J, Elfstrom KM, et al (2014). International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet, 383, 524-32 https://doi.org/10.1016/S0140-6736(13)62218-7
- Sankaranarayanan R, Esmy PO, Rajkumar R, et al (2007) Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet, 370, 398-406. https://doi.org/10.1016/S0140-6736(07)61195-7
- Sarma U, Mahanta J, Borkakoty B, et al (2015). Distribution of human papilloma virus infections of uterine cervix among women of reproductive age--a cross sectional hospital-based study from North East India. Asian Pac J Cancer Prev, 16, 1519-23. https://doi.org/10.7314/APJCP.2015.16.4.1519
- Sherigar B, Dalal A, Durdi G, et al (2010). Cervical cancer screening by visual Inspection with acetic acid - interobserver variability between nurse and physician. Asian Pac J Cancer Prev, 11, 619-22.
- Solomon D, Davey D, Kurman R, et al. (2002). The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA, 287, 2114-9. https://doi.org/10.1001/jama.287.16.2114
- Sowjanya AP, Jain M, Poli UR, et al (2005). Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis, 5, 116-23. https://doi.org/10.1186/1471-2334-5-116
- Sowjanya AP, Paul P, Vedantham H, et al (2009). Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev, 18, 1373-8 https://doi.org/10.1158/1055-9965.EPI-08-1171
- Tao K, Yan J, Yang H, et al (2014). Comparative study of the Cervista and Hybrid Capture 2 methods in detecting high-risk human papillomavirus in cervical lesions. Diagn Cytopathology, 42, 213-7. https://doi.org/10.1002/dc.23025
- Thulaseedharan JV1, Malila N, Hakama M, et al (2013). Effect of screening on the risk estimates of socio demographic factors on cervical cancer- a large cohort study from rural India. Asian Pac J Cancer Prev, 14, 589-94. https://doi.org/10.7314/APJCP.2013.14.1.589
- Wright TC Jr, Stoler MH, Sharma A, et al (2011). Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results. Am J Clin Pathol, 136, 578-86 https://doi.org/10.1309/AJCPTUS5EXAS6DKZ